Cargando…

Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion

Detalles Bibliográficos
Autores principales:	Tzartos, John S., Valsami, Serena, Tzanetakos, Dimitrios, Stergiou, Christos, Dandoulaki, Maria, Barbarousi, Despina, Psimenou, Erasmia, Velonakis, Georgios, Stefanis, Leonidas, Kilidireas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136045/ https://www.ncbi.nlm.nih.gov/pubmed/32241823 http://dx.doi.org/10.1212/NXI.0000000000000711

Ejemplares similares

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
por: Vakrakou, Aigli G., et al.
Publicado: (2021)

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis
por: Tzanetakos, Dimitrios, et al.
Publicado: (2022)

Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
por: Kazakou, Paraskevi, et al.
Publicado: (2023)

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes
por: Vakrakou, A. G., et al.
Publicado: (2018)

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
por: Pechlivanidou, Maria, et al.
Publicado: (2023)

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts
por: Tzanetakos, D., et al.
Publicado: (2020)

Alemtuzumab Plus Cyclosporine Treatment of the Autoimmune Hemolytic Anemia in an Adult Bowel Transplant
por: Lauro, A., et al.
Publicado: (2014)

Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis
por: Sharma, Parth, et al.
Publicado: (2022)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Early metabolic alterations in the normal‑appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: A proton MR spectroscopic study
por: Tzanetakos, Dimitrios, et al.
Publicado: (2023)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
por: Mir, Fazia A., et al.
Publicado: (2018)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS
por: Thomas, Katja, et al.
Publicado: (2016)

ODP482 Graves Orbitopathy Secondary to Alemtuzumab Infusion for Multiple Sclerosis
por: Alam, Mustafa, et al.
Publicado: (2022)

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm
por: Füreder, Wolfgang, et al.
Publicado: (2016)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Pulmonary hypertension in hemolytic anemias
por: Wahl, Shannon, et al.
Publicado: (2010)

About Microangiopathic Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2015)

Thymoma with Autoimmune Hemolytic Anemia
por: Suzuki, Kensuke, et al.
Publicado: (2014)

Ibuprofen-Induced Hemolytic Anemia
por: Barbaryan, Aram, et al.
Publicado: (2013)

Metformin-Induced Hemolytic Anemia
por: Kirkiz, Serap, et al.
Publicado: (2014)

Hemolytic Anemias: Autoimmune and Beyond
por: Krishnadasan, Ravi
Publicado: (2021)

Hemolytic anemia in COVID-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Vancomycin-Induced Hemolytic Anemia
por: Siddiqui, Fakeha, et al.
Publicado: (2023)

Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
por: Barcellini, W., et al.
Publicado: (2015)

Thrombotic Microangiopathic Hemolytic Anemia without Evidence of Hemolytic Uremic Syndrome
por: Özsoylu, Şinasi
Publicado: (2016)

Autoimmune Hemolytic Anemia Induced by Levofloxacin
por: Sheikh-Taha, Marwan, et al.
Publicado: (2014)

The Clinical Pictures of Autoimmune Hemolytic Anemia
por: Packman, Charles H.
Publicado: (2015)

Role of Complement in Autoimmune Hemolytic Anemia
por: Berentsen, Sigbjørn
Publicado: (2015)

Diagnostic approach to hemolytic anemias in the adult
por: Ruiz, Eloy F., et al.
Publicado: (2015)

Elderly female with Autoimmune hemolytic anemia
por: Dey, Anupam
Publicado: (2015)

Cardiac prostheses‐related hemolytic anemia
por: Alkhouli, Mohamad, et al.
Publicado: (2019)

Murine models of autoimmune hemolytic anemia
por: Howie, Heather L., et al.
Publicado: (2018)

Immunotherapy-associated autoimmune hemolytic anemia
por: Khan, Uqba, et al.
Publicado: (2017)

Autoimmune hemolytic anemia associated with babesiosis
por: Narurkar, Roshni, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nr2sec0k3vn8s720soqsmjnbua